These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2873399)

  • 21. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
    Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
    Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China.
    Li R; Huang L; Li J; Mo Z; He B; Wang Y; Wu X; Minutello M; Guinet-Morlot F; Pichon S
    Vaccine; 2013 Dec; 31(50):5940-7. PubMed ID: 24148575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postexposure prophylaxis for rabies with antiserum and intradermal vaccination.
    Chutivongse S; Wilde H; Supich C; Baer GM; Fishbein DB
    Lancet; 1990 Apr; 335(8694):896-8. PubMed ID: 1969993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers".
    Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P
    J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-rabies antibody titers among subjects who received rabies post-exposure prophylaxis with foreign-made rabies vaccines at the beginning and followed with Japanese rabies vaccine].
    Takayama N; Suganuma A; Kasai D; Kurai D
    Kansenshogaku Zasshi; 2002 Oct; 76(10):882-7. PubMed ID: 12448848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
    Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
    Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
    Lang J; Cetre JC; Picot N; Lanta M; Briantais P; Vital S; Le Mener V; Lutsch C; Rotivel Y
    Biologicals; 1998 Dec; 26(4):299-308. PubMed ID: 10403033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rabies and post-exposure prophylaxis in Thai children.
    Thongcharoen P; Wasi C; Sirikawin S; Chaiprasithikul P; Puthavathana P
    Asian Pac J Allergy Immunol; 1989 Jun; 7(1):41-6. PubMed ID: 2751769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally. (Results of a prospective randomized trial).
    Jaiiaroensup W; Lang J; Thipkong P; Wimalaratne O; Samranwataya P; Saikasem A; Chareonwai S; Yenmuang W; Prakongsri S; Sitprija V; Wilde H
    Vaccine; 1998 Oct; 16(16):1559-62. PubMed ID: 9711804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postexposure trial of a human diploid cell strain rabies vaccine.
    Anderson LJ; Sikes RK; Langkop CW; Mann JM; Smith JS; Winkler WG; Deitch MW
    J Infect Dis; 1980 Aug; 142(2):133-8. PubMed ID: 7410895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-rabies antibody levels observed in subjects who were bitten by supposed rabid animals abroad and received post-exposure immunization].
    Takayama N
    Kansenshogaku Zasshi; 1998 Oct; 72(10):1046-9. PubMed ID: 9847522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis.
    Warrell MJ; Warrell DA; Suntharasamai P; Viravan C; Sinhaseni A; Udomsakdi D; Phanfung R; Xueref C; Vincent-Falquet JC; Nicholson KG; Bunnag D; Harinasuta T
    Lancet; 1983 Aug; 2(8345):301-4. PubMed ID: 6135830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV).
    Fayaz A; Simani S; Janani A; Farahtaj F; Biglari P; Howeizi N; Eslami N
    Vaccine; 2011 May; 29(21):3742-5. PubMed ID: 21458608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The problem of rabies vaccination in children; an analysis of children bitten by rabid and rabid-suspected-animals.
    Munir M
    Paediatr Indones; 1980; 20(7-8):157-68. PubMed ID: 7443278
    [No Abstract]   [Full Text] [Related]  

  • 37. Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults.
    Kerdpanich P; Chanthavanich P; De Los Reyes MR; Lim J; Yu D; Ama MC; Mojares Z; Casula D; Arora AK; Pellegrini M
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006340. PubMed ID: 29874228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immunogenicity, safety and post-marketing surveillance of a novel adsorbed human diploid cell rabies vaccine (Rabivax) in Indian subjects.
    Sudarshan MK; Bhardwaj S; Mahendra BJ; Sharma H; Sanjay TV; Ashwathnarayana DH; Bilagumba G
    Hum Vaccin; 2008; 4(4):275-9. PubMed ID: 18682695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serologic response to rabies pre-exposure vaccination in persons with potential occupational exposure in Singapore.
    Lim PL; Barkham TM
    Int J Infect Dis; 2010 Jun; 14(6):e511-3. PubMed ID: 20018545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.